Clinical Guidelines
From the Journals

AHA Issues Pediatric Hypertriglyceridemia Statement

The scientific statement defines pancreatitis and atherosclerotic cardiovascular disease risk thresholds and outlines causes and management in youths.

Share

The American Heart Association's recent Scientific Statement on pediatric hypertriglyceridemia provides detailed screening, diagnostic, and management guidelines. Affecting 10-20% of U.S. children, this condition is associated with obesity and insulin resistance, leading to severe health risks like acute pancreatitis. Screening is recommended at ages 9-11 and 17-21, with lifestyle modifications being the first-line treatment. Genetic factors and second causes of hypertriglyceridemia are explored, including dietary and exercise recommendations, with limited pharmacotherapy options currently available.

Original Source(s)

AHA Issues Pediatric Hypertriglyceridemia Statement

The scientific statement defines pancreatitis and atherosclerotic cardiovascular disease risk thresholds and outlines causes and management in youths.

  • by Kathryn Wighton

  • February 26, 2026

  • 5 min

Related Content

Hypertension: Biomarkers Clarify Heart Failure Risk

Cardiac biomarkers help stratify heart failure risk among patients with prediabetes and hypertension.

BP Targets Across CKM Stages

Investigators assess stage-specific outcomes, safety, and net benefit of intensive blood pressure control in cardiovascular-kidney-metabolic syndrome.

Statin Side Effects Largely Unsupported by Trial Data

Most adverse effects listed on drug labels lack causal evidence, meta-analysis finds